- ►annals.org [PDF] PL Hibberd, NE Tolkoff-Rubin, D Conti, F … - Annals of internal medicine, 1995 - Am Coll Physicians • Objective: To determine why Required Request pol- icies, which mandate that
hospitals request donation from donor-eligible families, have not resulted in
in- creased organ procurement. • Setting: Stratified sample of 23 ... Cited by 166 - Related articles - BL Direct - All 5 versions
DJ Conti, BM Freed, TP Singh, M Gallichio, … - Archives of Surgery, 1995 - archsurg.highwire.org David J. Conti, MD; Brian M. Freed, PhD; T. Paul Singh, MD; Michael Gallichio,
MD; Scott A. Gruber, MD, PhD; Neil Lempert, MD ... Objective: To evaluate the
efficacy, safety, and cost of preemptive ganciclovir therapy in ... Cited by 53 - Related articles - BL Direct - All 4 versions
- ►annals.org N Singh, VL Yu, L Mieles, MM Wagener, RC … - Annals of internal medicine, 1994 - Am Coll Physicians Intervention: Patients were stratified by their CMV antibody status and the CMV
antibody status of the donor and were randomly assigned to one of two treatment
groups. Surveillance cultures for CMV (buffy coat and urine) were done ... Cited by 135 - Related articles - All 4 versions
M Martin, R Mañez, P Linden, D Estores, J … - Transplantation, 1994 - journals.lww.com 780 TRANSPLANTATION Vol. 58, No. 7 prevention of CMV disease in a population of
adult patients undergoing liver transplantation. MATERIALS AND METHODS
Randomization and study protocol. This prospective randomized trial was ... Cited by 78 - Related articles - BL Direct - All 3 versions
PL Hibberd, NE Tolkoff-Rubin, AB Cosimi, RT … - Transplantation, 1992 - ncbi.nlm.nih.gov A prospective study to investigate risk factors for CMV disease was conducted in
94 renal transplant recipients. CMV disease was defined as either unexplained
fever for greater than 3 days with viremia or unexplained fever for greater ... Cited by 178 - Related articles - All 3 versions
DC Brennan, KA Garlock, GG Singer, MA … - Transplantation, 1997 - cat.inist.fr 5 Barnes-Jewish Hospital. 6 Health Administration Program, Washington
University School of Medicine. 7 Department of Pediatrics, Washington University
School of Medicine. 8 Department of General Surgery, Transplantation ... Cited by 121 - Related articles - BL Direct - All 2 versions
DJ Winston, D Wirin, A Shaked, RW Busuttil - The Lancet, 1995 - Elsevier At the time of transplant, patients were randomised to receive either
ganciclovir (6 mg/kg body weight per day intravenously from postoperative day 1
to day 30, then 6 mg/kg per day Monday through Friday until day 100) or ... Cited by 179 - Related articles - BL Direct - All 6 versions
E Rondeau, B Bourgeon, MN Peraldi, P Lang, … - Nephrology Dialysis Transplantation, 1993 - ERA-EDTA Abstract. Cytomegalovirus (CMV) infection is the most frequent infectious
complication observed in renal transplant recipients and induces a significant
morbid- ity in these patients due to CMV disease itself and to associated ... Cited by 45 - Related articles - BL Direct - All 3 versions
TC Merigan, DG Renlund, S Keay, MR Bristow, … - New England Journal of Medicine, 1992 - content.nejm.org BACKGROUND. Because of the immunosuppression required, heart-transplant
recipients frequently have complications caused by cytomegalovirus (CMV),
including pneumonia, esophagitis, gastritis, and a syndrome of fever, ... Cited by 261 - Related articles - All 4 versions
- ►asnjournals.org [PDF] J Kletzmayr, H Kotzmann, T Popow-Kraupp, J … - Journal of the American Society of Nephrology, 1996 - Am Soc Nephrol Page 1. Journal of the American Society of Nephrology 325 Impact of High-Dose Oral
Acyclovir Prophylaxis on Cytomegalovirus (CMV) Disease in CMV High-Risk Renal ... Cited by 54 - Related articles - BL Direct - All 4 versions
